Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Chronic Inflammatory Bowel Disease | Research

Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study

Authors: Ingunn Johansen, Milada Cvancarova Småstuen, Stine Torp Løkkeberg, Vendel Ailin Kristensen, Marte Lie Høivik, Charlotte Lund, Bjørn Olsen, Vibeke Strande, Gert Huppertz-Hauss, Tone Bergene Aabrekk, May-Bente Bengtson, Petr Ricanek, Trond Espen Detlie, Svein Oskar Frigstad, Lars-Petter Jelsness-Jørgensen, Randi Opheim

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Patients with inflammatory bowel disease report multiple symptoms, but the relationships among co-occurring symptoms are poorly understood. This study aimed to examine the prevalence of symptoms and explore symptom clusters and possible associations between symptom clusters and socio-demographic and clinical variables in patients newly diagnosed with inflammatory bowel disease.

Methods

The IBSEN III study is a prospective population-based inception cohort of patients with inflammatory bowel disease. This study used patient data from the three largest hospitals in the study catchment area. The Memorial Symptom Assessment Scale was used to assess the prevalence of symptoms. Symptom clusters were identified using principal component analysis. Possible associations between socio-demographic and clinical variables and symptom cluster membership were estimated using regression analysis.

Results

Of the 573 patients (age, ≥18 years) diagnosed with inflammatory bowel disease, 350 (61.1%) completed the questionnaire (responders). Eleven symptoms were reported by >50% of the responders. The three most prevalent symptoms were bloating (84%), drowsiness (81%), and lack of energy (81%). Three symptom clusters were identified: psychological (56% of the patients), impaired energy (28%), and physical (16%) clusters. Multinomial regression analysis revealed that vitamin D deficiency was significantly associated with the impaired energy cluster (odds ratio=2.49, 95% confidence interval [1.00-6.2], p=0.05).

Conclusions

We found high symptom prevalence in patients newly diagnosed with inflammatory bowel disease. Three distinct symptom clusters were identified, and the psychological cluster includes >50% of the patients. Vitamin D deficiency is the only factor associated with cluster membership, namely the impaired energy cluster.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–24. PubMedPubMedCentralCrossRef Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–24. PubMedPubMedCentralCrossRef
3.
go back to reference O’Connor M, Bager P, Duncan J, Gaarenstroom J, Younge L, Detre P, et al. N-ECCO Consensus statements on the european nursing roles in caring for patients with Crohn’s disease or ulcerative colitis. J Crohns Colitis. 2013;7:744–64.PubMedCrossRef O’Connor M, Bager P, Duncan J, Gaarenstroom J, Younge L, Detre P, et al. N-ECCO Consensus statements on the european nursing roles in caring for patients with Crohn’s disease or ulcerative colitis. J Crohns Colitis. 2013;7:744–64.PubMedCrossRef
4.
go back to reference McCormick JB, Hammer RR, Farrell RM, Geller G, James KM, Loftus EV Jr, et al. Experiences of patients with chronic gastrointestinal conditions: in their own words. Health Qual Life Outcomes. 2012;10:25.PubMedPubMedCentralCrossRef McCormick JB, Hammer RR, Farrell RM, Geller G, James KM, Loftus EV Jr, et al. Experiences of patients with chronic gastrointestinal conditions: in their own words. Health Qual Life Outcomes. 2012;10:25.PubMedPubMedCentralCrossRef
5.
go back to reference Walker JR, Ediger JP, Graff LA, Greenfeld JM, Clara I, Lix L, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008;103:1989–97.PubMedCrossRef Walker JR, Ediger JP, Graff LA, Greenfeld JM, Clara I, Lix L, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008;103:1989–97.PubMedCrossRef
6.
go back to reference Gîlc-Blanariu GE, Ștefnescu G, Trifan AV, et al. Sleep Impairment and Psychological Distress among Patients with Inflammatory Bowel Disease-beyond the Obvious. J Clin Med. 2020;9(7):2304. Published 2020 Jul 20. https://doi.org/10.3390/jcm9072304. Gîlc-Blanariu GE, Ștefnescu G, Trifan AV, et al. Sleep Impairment and Psychological Distress among Patients with Inflammatory Bowel Disease-beyond the Obvious. J Clin Med. 2020;9(7):2304. Published 2020 Jul 20. https://​doi.​org/​10.​3390/​jcm9072304.
7.
go back to reference Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatology. 2021;6:359–70.CrossRef Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatology. 2021;6:359–70.CrossRef
8.
go back to reference Jelsness-Jørgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA. Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33:106.PubMedCrossRef Jelsness-Jørgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA. Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33:106.PubMedCrossRef
9.
go back to reference Devlen J, Beusterien K, Yen L, Ahmed A, Cheifetz AS, Moss AC. The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model. Inflamm Bowel Dis. 2014;20:545–52.PubMedCrossRef Devlen J, Beusterien K, Yen L, Ahmed A, Cheifetz AS, Moss AC. The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model. Inflamm Bowel Dis. 2014;20:545–52.PubMedCrossRef
10.
go back to reference Teruel C, Garrido E, Mesonero F. Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World J Gastrointest Pharmacol Ther. 2016;7:78–90.PubMedPubMedCentralCrossRef Teruel C, Garrido E, Mesonero F. Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World J Gastrointest Pharmacol Ther. 2016;7:78–90.PubMedPubMedCentralCrossRef
11.
go back to reference Farrell D, McCarthy G, Savage E. Self-reported Symptom Burden in individuals with inflammatory bowel disease. J Crohns Colitis. 2016;10:315–22.PubMedCrossRef Farrell D, McCarthy G, Savage E. Self-reported Symptom Burden in individuals with inflammatory bowel disease. J Crohns Colitis. 2016;10:315–22.PubMedCrossRef
13.
go back to reference Rubin DT, Siegel CA, Kane SV, Binion DG, Panaccione R, Dubinsky MC, et al. Impact of ulcerative colitis from patients’ and physicians’ perspectives: results from the UC: NORMAL survey. Inflamm Bowel Dis. 2009;15:581–8.PubMedCrossRef Rubin DT, Siegel CA, Kane SV, Binion DG, Panaccione R, Dubinsky MC, et al. Impact of ulcerative colitis from patients’ and physicians’ perspectives: results from the UC: NORMAL survey. Inflamm Bowel Dis. 2009;15:581–8.PubMedCrossRef
14.
go back to reference Kim H-J, McGuire DB, Tulman L, Barsevick AM. Symptom clusters: Concept Analysis and clinical implications for Cancer nursing. Cancer Nurs. 2005;28:270–82.PubMedCrossRef Kim H-J, McGuire DB, Tulman L, Barsevick AM. Symptom clusters: Concept Analysis and clinical implications for Cancer nursing. Cancer Nurs. 2005;28:270–82.PubMedCrossRef
15.
go back to reference DeVon HA, Vuckovic K, Ryan CJ, Barnason S, Zerwic JJ, Pozehl B, et al. Systematic review of symptom clusters in cardiovascular disease. Eur J Cardiovasc Nurs. 2017;16:6–17.PubMedCrossRef DeVon HA, Vuckovic K, Ryan CJ, Barnason S, Zerwic JJ, Pozehl B, et al. Systematic review of symptom clusters in cardiovascular disease. Eur J Cardiovasc Nurs. 2017;16:6–17.PubMedCrossRef
16.
go back to reference Lockwood MB, Chung S, Puzantian H, Bronas UG, Ryan CJ, Park C, et al. Symptom Cluster Science in chronic kidney disease: a Literature Review. West J Nurs Res. 2019;41:1056–91.PubMedCrossRef Lockwood MB, Chung S, Puzantian H, Bronas UG, Ryan CJ, Park C, et al. Symptom Cluster Science in chronic kidney disease: a Literature Review. West J Nurs Res. 2019;41:1056–91.PubMedCrossRef
17.
go back to reference Zhu Z, Zhao R, Hu Y. Symptom clusters in people living with HIV: a systematic review. J Pain Symptom Manage. 2019;58:115–33.PubMedCrossRef Zhu Z, Zhao R, Hu Y. Symptom clusters in people living with HIV: a systematic review. J Pain Symptom Manage. 2019;58:115–33.PubMedCrossRef
18.
go back to reference Jenkins BA, Athilingam P, Jenkins RA. Symptom clusters in chronic obstructive pulmonary disease: a systematic review. Appl Nurs Res. 2019;45:23–9.PubMedCrossRef Jenkins BA, Athilingam P, Jenkins RA. Symptom clusters in chronic obstructive pulmonary disease: a systematic review. Appl Nurs Res. 2019;45:23–9.PubMedCrossRef
19.
go back to reference Lenz ER, Pugh LC, Milligan RA, Gift A, Suppe F. The Middle-Range Theory of unpleasant symptoms: an update. ANS Adv Nurs. 1997;19:14–27.CrossRef Lenz ER, Pugh LC, Milligan RA, Gift A, Suppe F. The Middle-Range Theory of unpleasant symptoms: an update. ANS Adv Nurs. 1997;19:14–27.CrossRef
20.
go back to reference Perler BK, Ungaro R, Baird G, Mallette M, Bright R, Shah S, et al. Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort. BMC Gastroenterol. 2019;19:47.PubMedPubMedCentralCrossRef Perler BK, Ungaro R, Baird G, Mallette M, Bright R, Shah S, et al. Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort. BMC Gastroenterol. 2019;19:47.PubMedPubMedCentralCrossRef
21.
22.
go back to reference Kristensen VA, Opheim R, Perminow G, Huppertz-Hauss G, Detlie TE, Lund C, et al. Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern Norway. Scand J Gastroenterol. 2021;56:899–905.PubMedCrossRef Kristensen VA, Opheim R, Perminow G, Huppertz-Hauss G, Detlie TE, Lund C, et al. Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern Norway. Scand J Gastroenterol. 2021;56:899–905.PubMedCrossRef
23.
go back to reference Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;24:2–6.CrossRef Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;24:2–6.CrossRef
24.
go back to reference Harvey RF, Bradshaw JM. A simple index of Crohn`s-disease activity. Lancet. 1980;315:514.CrossRef Harvey RF, Bradshaw JM. A simple index of Crohn`s-disease activity. Lancet. 1980;315:514.CrossRef
26.
go back to reference Peyrin-Biroulet L, Panés J, Sandborn WJ, Vermeire S, Danese S, Feagan BG, et al. Defining Disease Severity in Inflammatory Bowel Diseases: current and future directions. Clin Gastroenterol Hepatol. 2016;14:348-54.e17.PubMedCrossRef Peyrin-Biroulet L, Panés J, Sandborn WJ, Vermeire S, Danese S, Feagan BG, et al. Defining Disease Severity in Inflammatory Bowel Diseases: current and future directions. Clin Gastroenterol Hepatol. 2016;14:348-54.e17.PubMedCrossRef
28.
go back to reference D’Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2218–24.PubMedCrossRef D’Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2218–24.PubMedCrossRef
30.
go back to reference Dignass AU, Gasche C, Bettenworth D, Birgegård G, Danese S, Gisbert JP, et al. European Consensus on the diagnosis and management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases. J Crohns Colitis. 2015;9:211–22.PubMedCrossRef Dignass AU, Gasche C, Bettenworth D, Birgegård G, Danese S, Gisbert JP, et al. European Consensus on the diagnosis and management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases. J Crohns Colitis. 2015;9:211–22.PubMedCrossRef
32.
go back to reference Kyle BD, Agbor TA, Sharif S, Chauhan U, Marshall J, Halder SLS, et al. Fecal calprotectin, CRP and leucocytes in IBD Patients: comparison of biomarkers with Biopsy results. J Can Assoc Gastroenterol. 2021;4:84–90.PubMedCrossRef Kyle BD, Agbor TA, Sharif S, Chauhan U, Marshall J, Halder SLS, et al. Fecal calprotectin, CRP and leucocytes in IBD Patients: comparison of biomarkers with Biopsy results. J Can Assoc Gastroenterol. 2021;4:84–90.PubMedCrossRef
33.
go back to reference Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30a:1326–36.PubMedCrossRef Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30a:1326–36.PubMedCrossRef
34.
go back to reference Hofsø K, Rustøen T, Cooper BA, Bjordal K, Miaskowski C. Changes over time in occurrence, severity, and distress of common symptoms during and after Radiation Therapy for breast Cancer. J Pain Symptom Manage. 2013;45:980–1006.PubMedCrossRef Hofsø K, Rustøen T, Cooper BA, Bjordal K, Miaskowski C. Changes over time in occurrence, severity, and distress of common symptoms during and after Radiation Therapy for breast Cancer. J Pain Symptom Manage. 2013;45:980–1006.PubMedCrossRef
35.
go back to reference Pallant J. SPSS survival manual: a step by step guide to data analysis using IBM SPSS. London: Open University Press; 2020.CrossRef Pallant J. SPSS survival manual: a step by step guide to data analysis using IBM SPSS. London: Open University Press; 2020.CrossRef
36.
go back to reference Field A, Miles J. Discovering statistics using SAS: (and sex, drug and rock`n`roll). Los Angeles: Los Angeles: SAGE; 2010. Field A, Miles J. Discovering statistics using SAS: (and sex, drug and rock`n`roll). Los Angeles: Los Angeles: SAGE; 2010.
37.
go back to reference Singh S, Blanchard A, Walker JR, Graff LA, Miller N, Bernstein CN. Common symptoms and stressors among individuals with inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2011;9:769–75.PubMedCrossRef Singh S, Blanchard A, Walker JR, Graff LA, Miller N, Bernstein CN. Common symptoms and stressors among individuals with inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2011;9:769–75.PubMedCrossRef
38.
go back to reference Karadag P, Morris B, Woolfall K. The information and support needs of patients living with inflammatory bowel disease: a qualitative study. Chronic Illn. 2022;18:356–69.PubMedCrossRef Karadag P, Morris B, Woolfall K. The information and support needs of patients living with inflammatory bowel disease: a qualitative study. Chronic Illn. 2022;18:356–69.PubMedCrossRef
39.
go back to reference Engel K, Homsi M, Suzuki R, Helvie K, Adler J, Plonka C, et al. Newly diagnosed patients with inflammatory bowel disease: the Relationship between Perceived Psychological Support, Health-Related Quality of Life, and Disease Activity. Health Equity. 2021;5:42–8.PubMedPubMedCentralCrossRef Engel K, Homsi M, Suzuki R, Helvie K, Adler J, Plonka C, et al. Newly diagnosed patients with inflammatory bowel disease: the Relationship between Perceived Psychological Support, Health-Related Quality of Life, and Disease Activity. Health Equity. 2021;5:42–8.PubMedPubMedCentralCrossRef
40.
go back to reference Czuber-Dochan W, Dibley LB, Terry H, Ream E, Norton C. The experience of fatigue in people with inflammatory bowel disease: an exploratory study. J Adv Nurs. 2013;69:1987–99.PubMedCrossRef Czuber-Dochan W, Dibley LB, Terry H, Ream E, Norton C. The experience of fatigue in people with inflammatory bowel disease: an exploratory study. J Adv Nurs. 2013;69:1987–99.PubMedCrossRef
41.
go back to reference Taft TH, Ballou S, Bedell A, Lincenberg D. Psychological considerations and interventions in inflammatory bowel Disease Patient Care. Gastroenterol Clin North Am. 2017;46:847–58.PubMedPubMedCentralCrossRef Taft TH, Ballou S, Bedell A, Lincenberg D. Psychological considerations and interventions in inflammatory bowel Disease Patient Care. Gastroenterol Clin North Am. 2017;46:847–58.PubMedPubMedCentralCrossRef
42.
43.
go back to reference Harris CS, Kober KM, Conley YP, Dhruva AA, Hammer MJ, Miaskowski CA. Symptom clusters in patients receiving chemotherapy: a systematic review. BMJ Support Palliat Care. 2022;12:10–21.PubMedCrossRef Harris CS, Kober KM, Conley YP, Dhruva AA, Hammer MJ, Miaskowski CA. Symptom clusters in patients receiving chemotherapy: a systematic review. BMJ Support Palliat Care. 2022;12:10–21.PubMedCrossRef
44.
go back to reference Radford SJ, McGing J, Czuber-Dochan W, Moran G. Systematic review: the impact of inflammatory bowel disease-related fatigue on health-related quality of life. Frontline Gastroenterol. 2021;12:11–21.PubMedCrossRef Radford SJ, McGing J, Czuber-Dochan W, Moran G. Systematic review: the impact of inflammatory bowel disease-related fatigue on health-related quality of life. Frontline Gastroenterol. 2021;12:11–21.PubMedCrossRef
45.
go back to reference Graff LA, Vincent N, Walker JR, Clara I, Carr R, Ediger J, et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:1882–9.PubMedCrossRef Graff LA, Vincent N, Walker JR, Clara I, Carr R, Ediger J, et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:1882–9.PubMedCrossRef
46.
go back to reference Jelsness-Jørgensen L-P, Moum B, Bernklev T. Worries and concerns among inflammatory bowel disease patients followed prospectively over one year. Gastroenterol Res Pract. 2011;2011:492034.PubMedPubMedCentralCrossRef Jelsness-Jørgensen L-P, Moum B, Bernklev T. Worries and concerns among inflammatory bowel disease patients followed prospectively over one year. Gastroenterol Res Pract. 2011;2011:492034.PubMedPubMedCentralCrossRef
47.
go back to reference Casati J, Toner BB, de Rooy EC, Drossman DA, Maunder RG. Concerns of patients with inflammatory bowel disease: a review of emerging themes. Dig Dis Sci. 2000;45:26–31.PubMedCrossRef Casati J, Toner BB, de Rooy EC, Drossman DA, Maunder RG. Concerns of patients with inflammatory bowel disease: a review of emerging themes. Dig Dis Sci. 2000;45:26–31.PubMedCrossRef
48.
go back to reference de Rooy EC, Toner BB, Maunder RG, Greenberg GR, Baron D, Steinhart AH, et al. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol. 2001;96:1816–21.PubMedCrossRef de Rooy EC, Toner BB, Maunder RG, Greenberg GR, Baron D, Steinhart AH, et al. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol. 2001;96:1816–21.PubMedCrossRef
49.
go back to reference Ballesio A, Zagaria A, Baccini F, Micheli F, Di Nardo G, Lombardo C. A meta-analysis on sleep quality in inflammatory bowel disease. Sleep Med Rev. 2021;60:101518.PubMedCrossRef Ballesio A, Zagaria A, Baccini F, Micheli F, Di Nardo G, Lombardo C. A meta-analysis on sleep quality in inflammatory bowel disease. Sleep Med Rev. 2021;60:101518.PubMedCrossRef
50.
go back to reference Huppertz-Hauss G, Høivik ML, Jelsness-Jørgensen LP, Opheim R, Henriksen M, Høie O, et al. Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: the IBSEN study. Scand J Gastroenterol. 2017;52:351–8.PubMedCrossRef Huppertz-Hauss G, Høivik ML, Jelsness-Jørgensen LP, Opheim R, Henriksen M, Høie O, et al. Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: the IBSEN study. Scand J Gastroenterol. 2017;52:351–8.PubMedCrossRef
51.
go back to reference Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007;22:1748–53.PubMedCrossRef Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007;22:1748–53.PubMedCrossRef
53.
go back to reference Garg M, Lubel JS, Sparrow MP, Holt SG, Gibson PR. Review article: vitamin D and inflammatory bowel disease–established concepts and future directions. Aliment Pharmacol Ther. 2012;36:324–44.PubMedCrossRef Garg M, Lubel JS, Sparrow MP, Holt SG, Gibson PR. Review article: vitamin D and inflammatory bowel disease–established concepts and future directions. Aliment Pharmacol Ther. 2012;36:324–44.PubMedCrossRef
54.
go back to reference O’Sullivan M. Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn? Proc Nutr Soc. 2015;74:5–12.PubMedCrossRef O’Sullivan M. Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn? Proc Nutr Soc. 2015;74:5–12.PubMedCrossRef
55.
go back to reference Gubatan J, Chou ND, Nielsen OH, Moss AC. Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2019;50:1146–58.PubMedCrossRef Gubatan J, Chou ND, Nielsen OH, Moss AC. Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2019;50:1146–58.PubMedCrossRef
56.
go back to reference Frigstad SO, Høivik ML, Jahnsen J, Cvancarova M, Grimstad T, Berset IP, et al. Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients. World J Gastroenterol. 2018;24:3293–301.PubMedPubMedCentralCrossRef Frigstad SO, Høivik ML, Jahnsen J, Cvancarova M, Grimstad T, Berset IP, et al. Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients. World J Gastroenterol. 2018;24:3293–301.PubMedPubMedCentralCrossRef
57.
go back to reference Meirte J, Hellemans N, Anthonissen M, Denteneer L, Maertens K, Moortgat P, et al. Benefits and disadvantages of electronic patient-reported outcome measures: systematic review. JMIR Perioper Med. 2020;3:e15588.PubMedPubMedCentralCrossRef Meirte J, Hellemans N, Anthonissen M, Denteneer L, Maertens K, Moortgat P, et al. Benefits and disadvantages of electronic patient-reported outcome measures: systematic review. JMIR Perioper Med. 2020;3:e15588.PubMedPubMedCentralCrossRef
58.
go back to reference Chang VT, Hwang SS, Thaler HT, Kasimis BS, Portenoy RK. Memorial Symptom Assessment Scale. Expert Rev PharmacoEcon Outcomes Res. 2004;4:171–8.PubMedCrossRef Chang VT, Hwang SS, Thaler HT, Kasimis BS, Portenoy RK. Memorial Symptom Assessment Scale. Expert Rev PharmacoEcon Outcomes Res. 2004;4:171–8.PubMedCrossRef
Metadata
Title
Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
Authors
Ingunn Johansen
Milada Cvancarova Småstuen
Stine Torp Løkkeberg
Vendel Ailin Kristensen
Marte Lie Høivik
Charlotte Lund
Bjørn Olsen
Vibeke Strande
Gert Huppertz-Hauss
Tone Bergene Aabrekk
May-Bente Bengtson
Petr Ricanek
Trond Espen Detlie
Svein Oskar Frigstad
Lars-Petter Jelsness-Jørgensen
Randi Opheim
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02889-y

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.